M. Hoffmann
bioRxiv · 2020–2021
A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Whom M. Hoffmann trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Hoffmann overall
Papers from M. Hoffmann's perspective
Ordered by how strongly the researchers M. Hoffmann trusts endorse each paper. Same corpus, a different order for every researcher.
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury (Nature Medicine)
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis (Journal of Pathology)
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China (Science)
- Angiotensin-converting enzyme 2 protects from severe acute lung failure (Nature)
- Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. (Proceedings of the National Academy of Sciences of the United States of America)
- A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry (Journal of Virology)
- Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry (Proceedings of the National Academy of Sciences of the United States of America)
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR (Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin)
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2 (Journal of Virology)
Their papers
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (2021) — 864 citations
- The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic (2021) — 838 citations
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells (2020) — 1,708 citations
- The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells (2020) — 742 citations
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (2020) — 18,267 citations